As of 2025-10-20, the EV/EBITDA ratio of Vir Biotechnology Inc (VIR) is -1.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VIR's latest enterprise value is 591.85 mil USD. VIR's TTM EBITDA according to its financial statements is -587.51 mil USD. Dividing these 2 quantities gives us the above VIR EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 16.1x | 14.6x |
| Forward P/E multiples | 15.2x - 17.6x | 15.8x |
| Fair Price | (62.68) - (66.57) | (62.76) |
| Upside | -1184.4% - -1251.7% | -1185.9% |
| Date | EV/EBITDA |
| 2025-10-17 | -1.01 |
| 2025-10-16 | -1.01 |
| 2025-10-15 | -1.08 |
| 2025-10-14 | -0.99 |
| 2025-10-13 | -1.03 |
| 2025-10-10 | -1.01 |
| 2025-10-09 | -1.07 |
| 2025-10-08 | -1.07 |
| 2025-10-07 | -0.98 |
| 2025-10-06 | -0.96 |
| 2025-10-03 | -1.00 |
| 2025-10-02 | -0.98 |
| 2025-10-01 | -0.99 |
| 2025-09-30 | -0.99 |
| 2025-09-29 | -0.97 |
| 2025-09-26 | -0.94 |
| 2025-09-25 | -0.87 |
| 2025-09-24 | -0.88 |
| 2025-09-23 | -0.86 |
| 2025-09-22 | -0.89 |
| 2025-09-19 | -0.87 |
| 2025-09-18 | -0.87 |
| 2025-09-17 | -0.78 |
| 2025-09-16 | -0.79 |
| 2025-09-15 | -0.77 |
| 2025-09-12 | -0.82 |
| 2025-09-11 | -0.88 |
| 2025-09-10 | -0.85 |
| 2025-09-09 | -0.88 |
| 2025-09-08 | -0.87 |
| 2025-09-05 | -0.89 |
| 2025-09-04 | -0.86 |
| 2025-09-03 | -0.94 |
| 2025-09-02 | -0.82 |
| 2025-08-29 | -0.81 |
| 2025-08-28 | -0.83 |
| 2025-08-27 | -0.88 |
| 2025-08-26 | -0.69 |
| 2025-08-25 | -0.68 |
| 2025-08-22 | -0.72 |
| 2025-08-21 | -0.68 |
| 2025-08-20 | -0.67 |
| 2025-08-19 | -0.67 |
| 2025-08-18 | -0.70 |
| 2025-08-15 | -0.71 |
| 2025-08-14 | -0.69 |
| 2025-08-13 | -0.72 |
| 2025-08-12 | -0.67 |
| 2025-08-11 | -0.65 |
| 2025-08-08 | -0.66 |